Learn more

ARCH PHARMALABS LTD

Overview
  • Total Patents
    27
  • GoodIP Patent Rank
    235,244
About

ARCH PHARMALABS LTD has a total of 27 patent applications. Its first patent ever was published in 2005. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and India. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and materials and metallurgy are SCHWEIZERHALL CHEM FAB, CHEER FINE PHARMACEUTICAL ANHUI CO LTD and KREWEL LEUFFEN GMBH.

Patent filings in countries

World map showing ARCH PHARMALABS LTDs patent filings in countries

Patent filings per year

Chart showing ARCH PHARMALABS LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Pai Ganesh Gurpur 14
#2 Mandal Arun Kanti 7
#3 Ranbhan Kamlesh Jayantilal 7
#4 Ujagare Ashish 5
#5 Chaudhari Bapu Atmaram 3
#6 Kamath Ajit Annu 3
#7 Ujagare Ashish Mohan 3
#8 Ghogare B N 3
#9 Kochrekar D A 3
#10 Ghogare Bhausaheb Nana 2

Latest patents

Publication Filing date Title
WO2020016903A1 An improved and commercially viable process for preparation of pyrrole derivatives with improved impurity profile & minimisation of unit operations.
WO2013080215A1 An improved process for the preparation of flupirtine and pharmaceutically acceptable salts thereof
WO2012123966A1 Process for the preparation of 4 -substituted -1, 4-dihydropyridines
WO2013093928A1 An improved process for preparing 2-oxindoles of formula i, a key raw material for making pharmaceutical drugs and intermediates thereof
WO2013011518A1 Process for the preparation of retigabine of the formula i and pharmaceutically acceptable salts thereof
WO2012153341A1 A process for the preparation of iloperidone and pharmaceutically acceptable salts thereof
WO2012049688A1 An improved process for the preparation of racemic 6, 6- dimethyl-3-azabicyclo-[3.1.0]-hexane and its salts, a key raw material for hcv inhibitor.
WO2012020424A1 A short process for the preparation of ziprasidone and intermediates thereof
WO2012077123A1 Purification of montelukast using a simulated moving bed
WO2012073249A1 A novel process for the preparation of 3-(benzyloxy)- benzenethiol, a key intermediate for the preparation of pharmaceutical drugs.
WO2012059933A1 A new process for preparing optically pure milnacipran and its pharmaceutically acceptable salts.
WO2011145102A1 A process for the preparation of n-methyl-o-aryloxy-propanamine derivatives and pharmaceutically acceptable salt thereof
EP2509973A1 Process for the preparation of imatinib and salts thereof
WO2009109992A1 Novel process for preparation of duloxetine and intermediates for use therein
WO2010032256A1 Process for preparing anhydrous rare earth metal halides
EP2279167A1 NOVEL PROCESS FOR THE PREPARATION OF 4-FLUORO-ALPHA-Ý2-METHYL -1-OXOPROPYL¨-GAMMA-OXO-N-ß-DIPHENYLBENZENEBUTANAMIDE AND PRODUCTS THEREFROM
WO2007017894A2 PREPARATION OF NOVEL CRYSTALLINE η(ETA) FORM OF PERINDOPRIL ERBUMINE
WO2007017893A2 Preparation of novel crystalline form of perindopril erbumine monohydrate
WO2007049294A1 An improved process for preparation of gemcitabine hydrochloride.
WO2007017886A1 Novel process for preparation of clopidogrel bisulphate polymorphic form i